title: Impact of trichostatin A and sodium valproate treatment on post-stroke neurogenesis and behavioral outcomes in immature mice.
abstract: Stroke in the neonatal brain frequently results in neurologic impairments including cognitive disability. We investigated the effect of long-term sodium valproate (valproate) and trichostatin A (TSA) treatment upon post-stroke neurogenesis in the dentate gyrus (DG) of stroke-injured immature mice. Decreased or abnormal integration of newborn DG neurons into hippocampal circuits can result in impaired visual-spatial function, abnormal modulation of mood-related behaviors, and the development of post-stroke epilepsy. Unilateral carotid ligation of P12 CD1 mice was followed by treatment with valproate, TSA, or vehicle for 2 weeks, bromodeoxyuridine (BrdU) administration for measurement of neurogenesis, and perfusion at P42 or P60. Behavior testing was conducted from P38-42. No detrimental effects on behavior testing were noted with TSA treatment, but mildly impaired cognitive function was noted with valproate-treated injured animals compared to normal animals. Significant increases in DG neurogenesis with both TSA and valproate treatment were noted with later administration of BrdU. Increased mortality and impaired weight gain was noted in the valproate-treated ligated animals, but not in the TSA-treated animals. In summary, the impact of histone deacetylase (HDAC) inhibition upon post-stroke subgranular zone neurogenesis is likely to depend on the age of the animal at the time point when neurogenesis is assessed, duration of HDAC inhibition before BrdU labeling, and/or the stage in the evolution of the injury.
authors: Department of Neurology and Developmental Medicine, Hugo Moser Kennedy Krieger Research Institute Baltimore, MD, USA.
authors: Shanu
authors: S
authors: George
authors: Shilpa D
authors: SD
authors: Kadam
authors: Natasha D
authors: ND
authors: Irving
authors: Geoffrey J
authors: GJ
authors: Markowitz
authors: Saba
authors: S
authors: Raja
authors: Anthony
authors: A
authors: Kwan
authors: Yushan
authors: Y
authors: Tu
authors: Huigen
authors: H
authors: Chen
authors: Charles
authors: C
authors: Rohde
authors: Dani R
authors: DR
authors: Smith
authors: Anne M
authors: AM
authors: Comi
keywords: anticonvulsants; behavioral outcomes; hippocampal neurogenesis; histone deacetylase inhibitors; neonatal stroke; trichostatin A; valproate
references: J Neuroinflammation. 2012 Apr 18;9:70
references: 22512781
references: Behav Brain Res. 2009 Jan 30;197(1):77-83
references: 18761039
references: J Pharmacol Exp Ther. 2007 Jun;321(3):892-901
references: 17371805
references: J Neurosci Res. 2009 Sep;87(12):2653-66
references: 19396874
references: J Child Neurol. 2005 Jul;20(7):582-7
references: 16159524
references: EMBO J. 2003 Jul 1;22(13):3411-20
references: 12840003
references: Front Psychiatry. 2011 Jan 07;1:153
references: 21423460
references: Nat Neurosci. 2007 Mar;10(3):355-62
references: 17277773
references: Epilepsy Res. 2008 Oct;81(2-3):107-13
references: 18538545
references: EMBO J. 2003 Mar 3;22(5):1168-79
references: 12606581
references: J Neurosci. 2011 Sep 7;31(36):12992-3001
references: 21900578
references: Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):2041-6
references: 12576549
references: Neuropharmacology. 2006 Sep;51(4):789-804
references: 16806297
references: Age (Dordr). 2007 Sep;29(2-3):87-96
references: 19424834
references: Alcohol. 2004 May;33(1):63-71
references: 15353174
references: ChemMedChem. 2012 Mar 5;7(3):425-39
references: 22234885
references: J Neurochem. 2009 Aug;110(4):1226-40
references: 19549282
references: Neuroreport. 2010 Apr 21;21(6):452-6
references: 20848732
references: Epilepsy Res. 2011 May;94(3):138-48
references: 21481568
references: Annu Rev Pharmacol Toxicol. 2005;45:495-528
references: 15822187
references: Trends Neurosci. 2009 Nov;32(11):591-601
references: 19775759
references: Neuroscience. 2010 Mar 10;166(1):15-22
references: 20006675
references: Biochim Biophys Acta. 2010 Oct-Dec;1799(10-12):840-53
references: 20833281
references: Epilepsy Behav. 2010 Aug;18(4):344-57
references: 20708575
references: Curr Mol Pharmacol. 2009 Jan;2(1):95-109
references: 20021450
references: Cell Res. 2011 Mar;21(3):381-95
references: 21321607
references: Eur J Neurosci. 2007 May;25(10):2973-81
references: 17509085
references: Cancer Res. 2004 Feb 1;64(3):1079-86
references: 14871841
references: Neuropharmacology. 2009 Feb;56(2):473-80
references: 19007798
references: J Neurosci. 2007 May 30;27(22):5967-75
references: 17537967
references: Behav Brain Res. 2012 Feb 14;227(2):470-9
references: 21801754
references: J Neurosci Res. 2009 Oct;87(13):2898-907
references: 19437554
references: J Neurosci. 1996 Mar 15;16(6):2027-33
references: 8604047
references: Ann N Y Acad Sci. 1999;886:23-36
references: 10667200
references: Hippocampus. 2012 May;22(5):1188-201
references: 21739523
references: EMBO J. 2001 Dec 17;20(24):6969-78
references: 11742974
references: J Biol Chem. 2001 Sep 28;276(39):36734-41
references: 11473107
references: J Appl Toxicol. 2008 Jul;28(5):628-37
references: 17994530
references: Pediatr Neurol. 2004 Oct;31(4):254-7
references: 15464636
references: J Neurosci. 2007 Jun 6;27(23):6128-40
references: 17553985
references: Neurobiol Dis. 2009 Apr;34(1):1-10
references: 19100327
references: Neuroscience. 2012 Sep 18;220:313-21
references: 22704966
references: J Neurol Neurosurg Psychiatry. 1957 Feb;20(1):11-21
references: 13406589
references: Brain Res. 1995 Aug 14;689(1):159-62
references: 8528702
references: Brain Res. 2008 May 7;1208:35-45
references: 18387598
references: Stroke. 2012 Sep;43(9):2430-6
references: 22811460
references: Neuron Glia Biol. 2010 May;6(2):93-107
references: 20388229